As filed with the Securities and Exchange Commission on January 27, 2006
Registration No. 333-51364
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
- --------------------------------------------------------------------------------
Post-Effective Amendment No. 1 to Form S-4
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
- --------------------------------------------------------------------------------
IVAX CORPORATION
(Exact name of registrant as specified in its charter)
- --------------------------------------------------------------------------------
Florida 2834 65-0507804
(State or other jurisdiction of (Primary Standard (I.R.S. Employer
incorporation or organization) Industrial Classification Identification
Code Number) Number)
4400 Biscayne Boulevard
Miami, Florida 33137
(305) 575-6000
(Address, including zip code, and telephone number, including area code, of
registrants' principal executive offices)
- --------------------------------------------------------------------------------
Richard S. Egosi
c/o Teva Pharmaceuticals USA, Inc.
425 Privet Road
Horsham, Pennsylvania 19044
(215) 293-6400
(Name, address, including zip code, telephone number, including area code,
of agent for service)
- --------------------------------------------------------------------------------
Copies to:
PETER H. JAKES, Esq.
JEFFREY S. HOCHMAN, Esq.
Willkie Farr & Gallagher LLP
787 Seventh Avenue
New York, New York 10019
(212) 728-8000
- --------------------------------------------------------------------------------
If the securities being registered on this Form are being offered in
connection with the formation of a holding company and there is compliance with
General Instruction G, please check the following box. |_|
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. |-|
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. |_|
- --------------------------------------------------------------------------------
-----------------------------------
DEREGISTRATION OF UNSOLD SECURITIES
-----------------------------------
20,241,462 shares of common stock of IVAX Corporation, par value $0.10 per
share (the "Common Stock") and the associated common stock purchase rights (the
"Common Stock Purchase Rights"), giving effect to the 5-for-4 stock split of the
Common Stock in May 2001 and the 5-for-4 stock split of the Common Stock in
August 2004, previously registered for sale to the public under this
Registration Statement are hereby withdrawn from registration. Such Common Stock
and Common Stock Purchase Rights represent all the securities remaining unsold
under this Registration Statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-4 and has duly caused this
Post-Effective Amendment No. 1 to the Registration Statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Miami,
State of Florida, on January 27, 2006.
IVAX CORPORATION
By: /s/ George S. Barrett
------------------------------
George S. Barrett
President (Chief Executive Officer)
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Post-Effective Amendment No. 1 to the Registration Statement has been
signed by the following persons in the capacities and on the dates indicated.
Name Title(s) Date
---- -------- ----
/s/ George S. Barrett President (Chief Executive Officer) and Director January 27, 2006
- ----------------------------
George S. Barrett
/s/ Mark W. Durand Chief Financial Officer (Principal Financial January 27, 2006
- ---------------------------- Officer and Principal Accounting Officer)
Mark W. Durand
/s/ William S. Marth Director January 27, 2006
- ----------------------------
William S. Marth
/s/ Richard S. Egosi Director January 27, 2006
- ----------------------------
Richard S. Egosi